Simon J. Crabb

Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First‐Line Docetaxel: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial (SAKK 08/11)

J. Bernhard, R. Winterhalder, S. Crabb, 2016, The Prostate.